Table 2.

Cardiac Mitochondrial Phospholipid Composition in SSM and IFM.

	Standard Chow		EPA+DHA		P Value
Fatty Acid	Sham	Infarct	Sham	Infarct	Infarct vs. Sham	EPA+DHA vs. STD
SSM
EPA (C20:5n3)	BQL	BQL	4.2±0.3‡	4.7±0.2‡	NS	<0.001
Palmitic Acid (C16:0)	12.5±0.8	11.3±0.4	11.1±0.4†	10.7±0.1	NS	0.035
Stearic Acid (C18:0)	18.6±0.2	18.1±0.1	17.0±0.3‡	17.2±0.1†	NS	<0.001
Oleic Acid (C18:1n9)	15.2±1.1	13.0±0.5#	12.5±0.2†	12.9±0.3	NS	NS
Linoleic Acid (C18:2n6)	21.6±0.3	20.9±0.7	21.5±0.4	18.4±0.5†	0.005	NS
IFM
EPA (C20:5n3)	BQL	BQL	4.2±0.2‡	4.0±0.2‡	NS	<0.001
Palmitic Acid (C16:0)	10.9±0.5	12.0±0.5	11.1±0.3	12.3±0.3#	0.007	NS
Stearic Acid (C18:0)	18.2±0.2	18.6±0.2	17.5±0.1†	18.0±0.1†	0.031	<0.001
Oleic Acid (C18:1n9)	13.7±0.9	12.5±1.0	11.8±0.2	11.2±0.7	NS	0.039
Linoleic Acid (C18:2n6)	21.8±0.4	21.9±0.8	21.8±0.4	20.6±0.4	NS	NS

Data are expressed as percent of total mitochondrial membrane phospholipid content. Data are the mean±SEM. n=7–8/group.

^#p<0.05 vs EPA+DHA sham, # p<0.05 vs sham,

^*p<0.001 vs sham,

^†p<0.05 vs standard chow,

^‡p<0.001 vs. standard chow sham. The Infarct vs. Sham column represents significant main effects of surgery. The EPA+DHA vs. STD column represents significant main effects of diet. BQL, Below Quantifiable Limits; NS, not significant.